Skip to content
Research Article Open access CC BY 3.0

Universal Leukoreduction Decreases the Incidence of Febrile Nonhemolytic Transfusion Reactions to Cellular Blood Components: A 5 Year Study

Dharmesh Chandra Sharma, Sunita Rai, Shruti Gupta, Bharat Jain

International Blood Research & Reviews · pp. 279–288 · Published 7 Jul 2014

10.9734/IBRR/2014/11610

Abstract

Background: Febrile nonhemolytic transfusion reactions (FNHTRs) are common complications associated with allogenic transfusion and it is caused by the leucocytes and cytokines released by leucocytes during storage of blood/ blood components. These reactions are generally not life threatening, but they are expensive in their management, evaluation, and associated blood-product wastage. 1st log prestorage universal leukoreduction (ULR) i.e. removal of Buffy coat is a useful and effective procedure in developing countries to control FNHTRs significantly. Aims and Objects: To know the efficacy of pre-storage 1st log universal leuckoreduction in controlling febrile nonhemolytic transfusion reactions (FNHTRs). Place and Duration of Study: Study was carried out at Blood Bank, Department of Pathology, G. R. Medical College, Gwalior from January 2009 to December 2013 (5years). Materials and Methods: Study was divided into control group (Year: 2009) and study group (Years: 2010-13). 14,292 recipients in control group and 45,064 in study group were transfused with non-leukoreduced and prestorage 1st log leukoreduced blood/ blood components respectively. Usefulness of prestorage 1st log ULR over non-leukoreduced blood/ blood components was observed, compared and discussed. Result: In the control group 610 (4.26%) out of 14,292 (p=0.0003) and in study group 381(0.84%) out of 45,064 (p=0.0003) recipients were reported to have FNHTRs. The comparative study showed significant reduction in FNHTRs from 4.26% to 0.84% (↓ 3.42%) (p=0.000001). Conclusion: 1st log Universal Leukoreduction (ULR) is a better option over Selective Leukoreduction (SLR) to prevent FNHTRs and it also helps the transfusion services of under-resourced developing countries in many ways.

Blood transfusion universal leukoreduction selective leukoreduction febrile non hemolytic transfusion reaction

References (29)

  1. 1 Clinical Outcomes Following Institution of the Canadian Universal Leukoreduction Program for Red Blood Cell Transfusions [DOI]
  2. 2 Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL‐6) levels in the plasma of stored platelet concentrates: relationship between TNF alpha and IL‐6 levels and febrile transfusion reactions [DOI]
  3. 3 Biologic effects of leukocytes present in transfused cellular blood products [DOI]
  4. 4 The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC [DOI]
  5. 5 Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs [DOI]
  6. 6 A randomized controlled trial comparing the frequency of acute reactions to plasma‐removed platelets and prestorage WBC‐reduced platelets [DOI]
  7. 7 Non-infectious complications of transfusion therapy [DOI]
  8. 8 Prevention of refractoriness and HLA-alloimmunization using filtered blood products [DOI]
  9. 9 Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial [DOI]
  10. 10 A prospective, randomized clinical trial of universal WBC reduction [DOI]
  11. 11 Leukodepletion Blood Filters: Filter Design and Mechanisms of Leukocyte Removal [DOI]
  12. 12 Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study [DOI]
  13. 13 Leukoreduced blood components: Advantages and strategies for its implementation in developing countries [DOI]
  14. 14 Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration [DOI]
  15. 15 A randomized trial of leukocyte-depleted platelet transfusion to modify alloimmunization in patients with leukemia [DOI]
  16. 16 Bedside filtration of blood products in the prevention of HLA alloimmunization--a prospective randomized study. Alloimmunisation Study Group [DOI]
  17. 17 Prevention of alloimmunization in patients with acute leukemia by use of white cell‐reduced blood components—a randomized trial [DOI]
  18. 18 Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage [DOI]
  19. 19 Effects of 3‐5 log10 pre‐storage leucocyte depletion on red cell storage and metabolism [DOI]
  20. 20 Multicenter Evaluation of Methods for Counting Residual White Cells in Leukocyte‐Depleted Red Blood Cells [DOI]
  21. 21 Universal Leukoreduction of Cellular Blood Components in 2001? [DOI]
  22. 22 A comparison of prestorage WBC‐reduced whole‐blood‐derived platelets and bedside‐filtered whole‐blood‐derived platelets in autologous progenitor cell transplant [DOI]
  23. 23 Inadequate white cell reduction by bedside filtration of red cell concentrates [DOI]
  24. 24 Prestorage leukocyte depletion: effect on leukocyte and platelet metabolites, erythrocyte lysis, metabolism, and in vivo survival.
  25. 25 Quality of blood components filtered before storage and at the beside: Implications for transfusion practice [DOI]
  26. 26 Leucofiltration of sickle cell trait blood “the blocker”: NBS London & S.E. experience [DOI]
  27. 27 Leukoreduced blood components: “You can filter now or you can filter later” [DOI]
  28. 28 Efficacy of Whole Blood Reconstituted (WBR) in Exchange Transfusion (ET) in Hemolytic Disease of New Born (HDN) —A Study of 110 Cases [DOI]
  29. 29 To filter blood or universal leukoreduction: what is the answer? [DOI]

Cited by 3

Non Infectious Complications Related to Blood Transfusion: An 11 year Retrospective Analysis in a Tertiary Care Hospital

J. Philip, A. Pawar, T. Chatterjee · Indian Journal of Hematology and Blood Transfusion · 2015

Showing 2 of 3 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

26

Page views

0

PDF downloads

3

Outbound clicks

3

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.